K-numberK242322
Device nameBone Marrow Biopsy Needle
ApplicantZhejiang Curaway Medical Technology Co., Ltd.
Product codeKNW
Device classClass II
Decision dateJan 24, 2025
DecisionSubstantially Equivalent
Regulation876.1075
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Bone Marrow Biopsy Needle is a manual, sterile, single-use disposable device designed to aspirate bone marrow and obtain core biopsy samples of bone and/or bone marrow. It consists of a stylet and cannula that work together to penetrate tissue, extract samples, and is supplied in two models (BNMAB-1 and BNMA/CB-1), with the latter including extraction accessories.

Technological characteristics

The subject device differs from the predicate in four ways: broader needle gauge range (9G–18G vs. 8G–13G), shorter needle lengths available (25–150 mm vs. 50–200 mm), a three-edge stylet tip instead of two-edge, and inclusion of additional biocompatibility test standards (ISO 10993-23). Core materials, cannula design, handle, sterilization method, and overall operation remain identical.

Test standards cited

ASTM F1980:2016 (packaging and shelf-life); ISO 10993-1:2018, ISO 10993-5:2009, ISO 10993-10:2021, ISO 10993-11:2017, and ISO 10993-23:2021 (biocompatibility); ISO 11135:2014 and ISO 11138-1:2017 (sterilization validation); ISO 10993-7:2008 (EO residuals); ISO 11737-2:2019 (sterility testing). Bench tests included puncture, torque, stiffness, toughness, and corrosion resistance.

Substantial equivalence argument

The devices share identical indications for use, same classification, materials, and operational mechanics. Design differences (gauge, length, stylet configuration) do not introduce new safety risks: larger gauges are tested and perform adequately, shorter needles are inherently safer than longer ones for the same diameter, and three-edge stylets are common in medicine with improved cutting efficiency. Biocompatibility testing covers the predicate's scope and exceeds it. Ex vivo sample quality comparison testing demonstrates substantial equivalence in performance.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →